Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Oct 26, 2011

Premium

Bernhard Sixt has resigned as CEO of Agendia, the company said this week.

Sixt, a co-founder of the company who served at its helm since 2003, will remain with Agendia in an "advisory capacity."

Agendia has tapped David Macdonald to replace Sixt as CEO. He previously served as the company's chief operating officer. Prior to that, he worked at Quest Diagnostics, Behring Diagnostics, and Novo Medical.

Macdonald holds a BS in management and finance from Northeastern University and an MBA from Babson College.

Agendia also said that Colin Goddard has joined its supervisory board of directors. Goddard is CEO of Coferon.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.